• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BXN

BIOXYNE LIMITED - News & Media

12.9% ! 2.7¢
Market Cap $58.45M  !

Bioxyne Limited is an Australia-based international consumer health and pharmaceutical... Bioxyne Limited is an Australia-based international consumer health and pharmaceutical company. The Company is focused on health and wellness products, psychotropic and investigational medicines. The Company operates through three segments: Wholesale PCC/USA, Consumer Health Products UK/ EU/JPN, and Pharmaceuticals AUS. Its subsidiary, Breathe Life Sciences (BLS) manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabidiol (CBD), cannabis extracts, vitamins, manuka honey, skin care products and mushroom complexes. BLS operates in Australia, the United Kingdom, Japan, and Europe with four accredited manufacturing facilities across four countries Japan, Australia, the United Kingdom, and Czechia. The Company direct sales arm and has developed a range of functional food products containing ingredients sourced exclusively from New Zealand and sold in Asia.More

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
2.7¢
Change
-0.004(12.9%)
Mkt cap ! $58.45M
Open High Low Value Volume
3.1¢ 3.2¢ 2.7¢ $249.2K 8.379M

Buyers (Bids)

No. Vol. Price($)
5 1096318 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 150000 1
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
BXN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.